Usage and perceptions of a mobile self-management application for people with type 2 diabetes: qualitative study of a five-month trial by Tatara, Naoe et al.
Usage and Perceptions of a Mobile Self-Management Application for People with Type 2 
Diabetes: Qualitative Study of a Five-Month Trial
Naoe Tataraa, b, c, Eirik Årsanda, b, Tone Bratteteigc, Gunnar Hartvigsenb, a
a Norwegian Centre for Integrated Care and Telemedicine, University Hospital of North Norway, Tromsø, Norway
b Department of Computer Science, University of Tromsø, Tromsø, Norway
c Design of Information Systems Group, Department of Informatics, University of Oslo, Oslo, Norway
Abstract 
Despite a growing number of clinical-intervention studies of
mobile applications for diabetes self-management, details of 
participants’ engagement with the intervention tools and of 
usability and feasibility issues are seldom reported. The Few 
Touch application is a mobile-phone-based self-management 
system for people with Type 2 diabetes mellitus (T2DM) de-
veloped by involving patient-users in design processes from an 
early phase to a long-term trial. An improved version was 
tested in a five-month trial by 11 individuals either with T2DM 
or at high risk of T2DM. Results showed clearer correlations 
between usage and perceived usefulness among these individ-
uals compared with those involved in the design process.
However, feedback on usability issues was mostly consistent 
between the two trials. This study therefore confirmed: 1) the
value of including patient-users not only in design-concept 
development but also in a long-term trial to identify as many 
factors critical to usability and usage as possible, and 2) the
importance of reflecting their feedback in design iterations to 
minimize the number of critical factors.
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Introduction  
To prevent complications in patients with Type 2 diabetes 
mellitus (T2DM), proper self-management is essential [1,2].
Nevertheless, poor adherence to treatment regimens is com-
monly observed [3]. Technological evolution and pervasive-
ness of mobile phones have boosted research efforts to use 
mobile phones as a terminal of intervention for diabetes treat-
ment to improve this situation [4–6]. However, due to consid-
erable differences in study design and lack of reporting details 
on participants’ engagement with the intervention tools, it is
difficult to identify factors that may have positive effects
[4,5,7]. Additionally, many studies fail to report details of 
usability issues and of user-centered design [7], which will be 
useful to understand motivational factors and barriers regard-
ing use of the tool.  
The Few Touch Application (FTA) is a mobile-phone-based 
application for self-management by patients with T2DM. It 
was designed by involving patients with T2DM, then tested on 
the same patients in a long-term trial (“Trial I”) in which the 
FTA design was iteratively updated based on their feedback
[8,9]. Our analyses of the results from the first year of Trial I
clarified mechanisms of FTA usage and identified factors as-
sociated with usability and usage in a long-term perspective
[10]. Following this study, we aimed to find out whether these
findings were applicable to individuals with T2DM in general.
Therefore, the FTA was subjected to a five-month trial (“Trial
II”), in which we qualitatively researched how the FTA was 
used and perceived by individuals who had not been involved 
in the FTA design process. This paper presents findings from 
Trial II and compares them with the findings from the first 
year of Trial I.
Materials and Methods 
Tested application: the Few Touch Application (FTA)
The FTA tested in Trial II consists of a software “Diabetes 
Diary” implemented on a mobile phone HTC Touch 2 with 
Windows Mobile 6.5 (HTC Corporation, Taiwan) and 
OneTouch Ultra 2 blood glucose (BG) meter (Lifescan Inc., 
Milpitas, CA) connected with a Polytel Bluetooth adapter 
(Polymap Wireless, LLC, Tucson, AZ). The start screen of the 
Diabetes Diary offers access to each function and to the mo-
bile phone’s home screen (Figure 1 (a)). The main compo-
nents of the FTA are a BG sensor system with automatic wire-
less data transmission from the BG meter, a nutrition habit
(NH) recording system, a physical activity (PA) recording 
system, goal-setting functions for physical activities and nutri-
tion habits, and information including user instructions for the 
FTA, an encyclopedia with approximately 400 topics relevant
to diabetes, and a tips bank containing 80 concise tips. Though 
some design updates were made after publishing previous 
work [8,9], some of which are presented in a previous publica-
tion [10], design details of most of the functions can be found 
in other previous publications [8,9].
The major difference between the FTA version used in Trial II
and the version presented previously [8–10] is a function to 
record PA. Due to difficulties with production of the required 
number of our tailored step counters, we designed a manual 
PA recording system during Trial I. To comply with the “sim-
ple and as easy as possible” design principle for the FTA 
while following recommendations by the Norwegian Direc-
torate of Health [11] and reflecting feedback on step counter 
use by the patients in Trial I [8–10], we employed two types 
of information to record: time and intensity of PA. The new 
PA recording system enables recording PA time like a stop-
watch (Figure 1 (b), (c)). Time recording runs as a background 
process so that users can switch the phone to sleep mode or 
use other functions. While time is being recorded, the Activity 
icon (“Aktivitet” in Norwegian) on the start screen of the Dia-
betes Diary continues blinking as a reminder to the user. 
Pressing the Stop (“stopp” in Norwegian) button prompts the 
user to confirm and if necessary adjust the time and date (Fig-
ure 1 (d)), then to set the intensity level of the completed PA
(Figure 1 (e)). Pressing the Save (“lagre” in Norwegian) but-
ton displays a feedback screen (Figure 1 (e)) with a bar chart
of accumulated minutes of PA by intensity level for the last 
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seven days, together with bars indicating progress toward set 
goals. When a goal is achieved, a yellow plain circle next to a 
progress bar turns to a smile emoticon. Two goals can be set 
for PA: daily and weekly accumulated time. Both are set 
based on one of the three intensity levels: high, moderate or 
low (“høy”, “moderat” and “lav” in Norwegian). This design 
gives users some flexibility to set goals depending on their 
plan and capacity. As Figure 1 (b) and (c) show, users can 
view the feedback screen by pressing the Status button. 
Trial II settings
Trial II was administered as part of the “Motivation with Mo-
bile project” [12], which aimed to strengthen a “Motivation 
Group” course for patient-oriented learning arranged in the
city of Harstad in northern Norway. The Motivation Group 
concept was initiated by the Norwegian Diabetes Associa-
tion to offer opportunities to people with T2DM for helping 
each other to improve their lifestyle through regular meetings, 
typically held weekly [13]. A group activity is led by a repre-
sentative patient with T2DM. It is locally organized by gather-
ing people with T2DM or at high risk of T2DM. The 11 par-
ticipants in the Motivation with Mobile project received in-
formation about Trial II, including the right to withdraw at any 
time without providing reasons and to choose whether to an-
swer questionnaires; they agreed to participate in Trial II. The 
local regional ethical committee regarded Trial II as outside 
their scope of approval authority. The study protocol was 
therefore approved by the privacy officer at our local regional 
hospital.
To enable the participants to familiarize themselves with the 
phone, it was initially supplied without the Diabetes Diary. A 
week later, the Diabetes Diary was installed on the phone, a
BG meter with a Bluetooth transmitter attached was provided,
and the Diabetes Diary functions were explained to the partic-
ipants. It was emphasized that the FTA could and should be 
used in a way that the participants considered useful and that
usage was entirely voluntary.
Data collection
We used mixed methods, as we did for analysis of results from 
Trial I. As quantitative data, data recorded by the BG sensor 
system as well as the NH and PA recording systems were col-
lected at the end of the study. To collect qualitative data, we 
distributed an original questionnaire consisting of 74 major 
questions at the end of Trial II. The questions and options for 
answers were designed based on the results of qualitative 
analysis of the results from the first year of Trial I. This meth-
od enabled us to analyze the results systematically and effi-
ciently while gaining deep insight into the role that the FTA 
played in the participants’ self-management activities. Due to 
limited time for answering the questionnaire at a meeting, 
most of the questions were in multiple-choice format with an 
option to add free-text comments. The original questionnaire 
covered the following themes:
1. Clinical characteristics
2. The BG sensor system 
3. The PA recording system 
4. The NH recording system,
5. The tips bank (excluding other parts of the information 
resource function) 
6. The FTA as a whole application.
Major topics addressed under themes 2-6 were1:
1. Current level of self-management activity (a. frequency 
of BG measurements, b. frequency and length of PA, c.
amount of fruit/vegetable/berry intake and frequency of 
meals with high/low carbohydrate content)
2. Degree of change in level of each self-activity de-
scribed in Topic 1 compared with its level before using 
the FTA (2-4)
3. Reasons for change/no change in status of each self-
management activity (2-4)
4. Level of satisfaction with the current status of each 
self-management activity (2-4), self-management of 
diabetes in total, and knowledge of their diabetes (6)
5. Agreement on motivational effect of a function (2-5)
6. Level of satisfaction with a function (2-5)
7. Perceived usefulness (5 and 6)
8. Features that they appreciate (2-5) and that they con-
sider would increase motivation to use the FTA (6)
To supplement the answers to questions about FTA usability,
a focus group session was held two months after the Trial II
start.
The informed consent form for the Motivation with Mobile 
project included information that answering individual ques-
tions was voluntary.
Analysis of the data
To explore how the participants used the FTA over time, we 
focused on the number of days on which any data were rec-
orded rather than the number of records or contents of records. 
We employed “usage rate,” defined as the number of days per 
week [10] on which each function was used. A non-parametric 
test, the Mann-Kendall trend test [14], was applied on usage 
rates for weeks in which each function was available for seven 
days to examine usage trends over time. The test statistic tau is 
a measure of the monotonicity of the trend. Tau=1 means a 
monotonic increase; tau=0 indicates no trend either way; tau=-
1 means a monotonic decrease. Degrees of usage of each func-
tion and usage of functions in combination were also meas-
ured as percentages of the duration in which the FTA was 
available for each participant.
1 The numbers in parenthesis below correspond to themes described 
above
Figure 1 – Screenshots of the main page of Diabetes Diary (a) and the physical activity recording system (b-f)
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Answers from the questionnaires were collated to the results 
of analysis above to provide a better understanding of partici-
pants’ experience of the FTA.
Results 
Characteristics of the participants
Hereafter, we use the code “HPxx” to indicate a specific par-
ticipant, where “xx” shows the participant’s ID number in 
Trial II. The 11 participants (seven men and four women, age 
ranged from 40 to 73 with a mean age of 57.2 (Standard Devi-
ation (SD): 8.6)) consisted of 10 patients with T2DM and one 
participant at high risk of T2DM (HP07). For the 10 partici-
pants with T2DM, disease duration ranged from two to 20 
years (HP05 did not answer this question) with a mean dura-
tion of 10.3 (SD: 7.1). Regarding diabetes treatment, two 
(HP02 and HP09) used both insulin and oral medications, two 
(HP01 and HP11) did not use either insulin or oral medication, 
one (HP10) used only insulin, and the other five used only oral 
medications. Only HP05 had used PC-based software for dia-
betes self-management before participation in Trial II. None 
of the participants had previously used a mobile-phone-based
self-management system.
Usage of the FTA and experiences
The FTA was available for 21 weeks for all the participants 
except HP07, who started participating in the Motivation with 
Mobile project six weeks later than the others and therefore 
used the FTA for 15 weeks. After analysis of the recorded data 
and questionnaire responses, we found that the participants 
could be roughly divided into three groups: frequent use with 
positive experience, moderate use with neutral experience, and 
little use with mixed experience. Key results of the analysis of 
recorded data are summarized in Table 1, Table 2, and Figure 
2. Table 1 shows the mean and SD of degrees of usage among 
the participants in each group. Figure 2 shows degrees of us-
age of the FTA by each participant with color codes depend-
ing on the number of data types (BG values, NH, or PA) rec-
orded on a day. Table 2 shows results from the Mann-Kendall 
trend test on usage rates over the trial duration for each func-
tion. Where no trend was observed (tau=0), p-values are 
shown as not applicable (N/A). A significantly (p < .05) in-
creasing trend is indicated by an asterisk (*) while a signifi-
cantly decreasing trend is indicated by a dagger (†). Key re-
sults that specifically characterize each group are described 
under the following sub-sections together with characteristics 
of usage.
Group A (HP02, HP04, HP09 and HP10): Frequent use 
with positive experience
Participants in Group A used the BG sensor system frequently 
throughout Trial II compared with the other participants (Ta-
ble 1). HP02 and HP04 used the BG sensor system literally 
every day during the trial. Usage rates of the BG sensor sys-
tem by HP09 and HP10 showed an increasing trend (Table 2). 
HP02 experienced minor problems with data transmission
Table 1 – Difference in degrees of usage, mean and SD (in 


















Group A Group B Group C
Figure 2 – Degree of FTA usage depending on the number of 
data types recorded
Table 2 – Results (tau-values) from Mann-Kendall trend test 
(the values in parentheses are p-values.) 
from the BG meter to Diabetes Diary, but the other three par-
ticipants did not experience any problems with the BG sensor 
system. They often used both or either PA and/or NH record-
ing systems on the days on which they used BG sensor system
(Figure 2). H04 regarded choosing a category to record nutri-
tion habit as difficult and gave score of two (indicating “dis-
satisfied”) on the 5-point Likert scale for the question asking 
about satisfaction with the NH recording system. Except for 
this and a few other questions to which neutral answers were 
given, most of the answers were positive. All four participants 
increased the frequency of their BG measurements and PA, as 
well as the length of PA sessions, because they found each 
function motivating and/or each function made the partici-
pants more conscious about self-management activity. Usage 
rates of the PA and/or NH recording systems by HP02, HP09 
and HP10 also showed an increasing trend, while usage rates
for the NH recording system by HP04 showed a decreasing
trend (Table 2). Regarding the FTA in total, all four partici-
pants gave the best score (seven on the 7-point Likert scale) to






A 94% (8%) 46% (23%) 48% (31%)
B 47% (18%) 29% (13%) 41% (21%)










02 0.00 (N/A) 0.45 (.008) * 0.38 (.025) *
04 0.00 (N/A) -0.02 (.92) -0.61 (<.001) †
09 0.42 (.020) * 0.09 (.65) 0.61 (<.001) *
10 0.42 (.020) * 0.50 (.002) * 0.31 (.10)
B
03 -0.01 (.98) -0.07 (.69) -0.13 (.46)
07 0.12 (.60) 0.47 (.033) * 0.38 (.074)
11 -0.61 (<.001) † 0.05 (.78) -0.33 (.050)
C
01 0.01 (N/A) -0.30 (.10) -0.14 (0.44)
05 0.38 (.031) * -0.31 (.12) -0.02 (.95)
06 -0.28 (.10) -0.42 (.017) † -0.38 (.039) †
08 -0.15 (.39) -0.45 (.018) † -0.15 (.45)
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perceived usefulness of the FTA for control over diabetes;
they were all satisfied with both current self-management and 
knowledge about their diabetes, and the levels of satisfaction
were higher than before they started using the FTA.
Group B (HP03, HP07 and HP11): Moderate use with rela-
tively neutral experience
Participants in Group B used all three functions moderately
(Table 2). Answers to the questionnaire showed different ex-
periences between HP07 (the non-diagnosed tester) and the 
other two. HP07 gave positive answers regarding motivational 
effect and level of satisfaction with all the functions. HP07 did 
not change the amount of fruit/vegetable/berry intake, which 
had been 300-600 gram (2-4 portions) daily2, because the NH 
recording system was not perceived as useful for HP07 to in-
crease the amount. The other self-management activities were,
however, improved because HP07 became more conscious 
and/or each function was motivating enough. In contrast,
HP03 and HP11 answered that there was no change in self-
management activities or level of satisfaction with their self-
management and knowledge of their diabetes through using 
each function or the FTA as a whole. They gave a neutral an-
swer (three on the 5-point Likert scale) to all the questions 
asking their opinion on the motivational effect of each func-
tion. They considered that they had been motivated enough or 
satisfied enough before starting to use the FTA, and on this 
basis they did not perceive the FTA as useful. In addition, 
HP11 experienced a problem with data transmission from the 
BG meter to Diabetes Diary since midway (late November 
2010) in Trial II, which caused HP11 to discontinue using the 
BG sensor system (as shown in Table 2).
Group C (HP01, HP05, HP06 and HP08): Little use of the
NH and PA recording systems with mixed experiences
Participants in Group C used the NH and PA recording sys-
tems very little (Table 1). Regarding the BG sensor system, 
only HP01 used it often (at a mean usage rate of 5.9 (SD:1.5)),
while the other three used it very moderately (at mean usage 
rates of 1.6 (SD:2.4), 2.2 (SD:2.2) and 2.6 (1.7) for HP05, 
HP06 and HP08, respectively). While HP05 and HP08 did not 
change frequency of BG measurements, HP01 and HP06 in-
creased it (less than doubled, scored four on the 5-point Likert 
scale). HP01, HP05 and HP06 agreed about the motivational 
effect of the BG system as well. However, HP01, HP05 and 
HP08 experienced problems with BG data transmission. HP05 
clearly stated that s/he did not use the PA or NH recording 
system at all and that s/he continued using the same PC-based 
software for self-management that s/he had used before partic-
ipating in Trial II rather than using the FTA. HP05 also 
showed a strong preference for having the Diabetes Diary on 
his/her own mobile phone, but not the provided phone. HP01, 
HP06 and HP08 were all “satisfied” (scored four on the 5-
point Likert scale) with the PA recording system, but they did 
not change the PA frequency or length because they had been 
satisfied with their previous PA level. In contrast, the NH re-
cording system was considered either neutral or negative re-
garding motivational effect and satisfaction with the function.
These three participants did not change the amount of vegeta-
ble/fruit/berry intake, which was 0-300 gram (0-2 portions) 
daily, because the NH recording system was not considered 
useful enough for them to increase the amount. 
Usability of the FTA
Answers to questions under Topic 8 themes 2-6, described in 
the previous section, and feedback we received in the focus 
2 Norwegian Diabetes Association recommends 750 gram (5 por-
tions) daily
group interview revealed FTA usability issues. Firstly, many 
usability problems with the mobile phone employed were re-
ported regardless of the participants’ age. One participant said 
that s/he was not using the provided phone as his/her personal 
mobile phone, but only as a terminal for the FTA. Regarding 
usability of the BG sensor system and the tips bank, most par-
ticipants appreciated the features that the participants in Trial I
had also liked. Suggestions for improvement were mostly 
about relatively minor issues, and were also generally in line 
with the feedback we obtained in Trial I. Most of the design
features of the PA recording system were perceived positively 
in general (HP05 did not answer corresponding questions). 
Additional feedback on potential improvements included set-
ting the time frame for the bar chart and the weekly goal to a
calendar week rather than the last seven days; making it possi-
ble to edit saved records if they had been saved by mistake;
displaying intensity levels more accurately on the feedback 
screen, to reflect a choice on screen (e) in Figure 1; and ena-
bling more specific data recording including activity types.
Concrete suggestions for improving the NH recording system 
were also consistent with the results from Trial I. However, 
the participants’ level of satisfaction regarding how easy it
was to record NH and to understand the feedback screens was 
lower than in Trial I, indicated by the greater number of par-
ticipants who gave a negative score on the 5-point Likert scale 
for each issue (three participants for ease of recording and four 
participants for ease of understanding the feedback screens, 
out of eight who answered these questions) than a positive 
score (two and three participants, respectively). No partici-
pants gave a negative score to the same questions in Trial I. In 
the focus group session, we became aware that many partici-
pants had had problems in deciding on a category to record. 
They wished that user instructions had provided better infor-
mation. Nine participants showed a preference for a possibility 
to record details of nutrition habits as well.
Discussion 
This study aimed to research qualitatively how individuals in a 
broader population with T2DM or at high risk of T2DM had 
used and perceived a mobile self-management application, the 
FTA, which had been designed with intensive involvement of
patient-users. User involvement in design processes has been 
deemed important to ensure that the resulting system ade-
quately meets the needs of users [15]. Considering that the 
feedback on FTA usability issues in Trial I and Trial II was 
fairly consistent in both positive and negative aspects, this 
study primarily confirmed the value of including a long-term 
trial in a design process involving patient-users. This made it 
possible to identify factors associated with usability and usage 
in a long-term perspective. Conducting a long-term trial of a 
working prototype by recruiting new patients demands far 
greater resources than continuing involvement of the same 
patients in a trial. This study also confirmed the importance of 
performing enough design iterations to minimize the number 
of critical factors for usability and longitudinal usage. In fact,
some of the critical opinions on design of the nutrition habits 
(NH) recording system were also given in Trial I. Even though 
many cycles of iteration on the design and functionalities were 
performed before Trial II, we were not able to address all usa-
bility problems. For the participants in Trial II, a clearer corre-
lation was observed between perception of a function and us-
age of the function in both negative and positive ways, com-
pared with results from Trial I. Decreasing trends in usage 
rates were observed among the participants in Group C who 
used each function very little; HP04 who was dissatisfied with
the NH recording system due to difficulty in choosing appro-
priate category to register, and HP11 who had problems with 
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data transmission of the BG sensor system. In contrast to Trial
I, we could not identify any cases in Trial II where a partici-
pant stopped using the FTA or a function of it because s/he
had learned enough about his/her diabetes by using the FTA.
On the contrary, an increasing trend in usage rates was ob-
served among five participants. Three out of the five were in 
Group A. Increasing trends in usage rates were observed for 
two functions for each of the three participants. This phenom-
enon implies that perceived usefulness has a greater impact on 
the degree of usage for the individuals with T2DM or at high 
risk of T2DM in general than those who were involved in the 
design process. Because Trial II was shorter than Trial I, how-
ever, additional follow-up of the participants may be neces-
sary to study how their usage changes over a longer duration.
Given the purpose and characteristics of the Motivation 
Group, the Trial II participants may have had even higher mo-
tivation than the Trial I participants. Although we did not 
measure their motivation level at the beginning of Trial II, 
possibly high level of their motivation may be considered as a
limitation of this study. For technical feasibility piloting or 
design processes, however, settings like Motivation Group
where regular meetings are held will be suitable. A new re-
search question arises about the influence of such meetings on 
use of an intervention tool or design input, which needs to be
investigated in future work.
Conclusion 
One of the main findings from this study is that perceived use-
fulness implies a greater impact on the degree of usage for the 
individuals with T2DM or a high risk of T2DM in general 
than for those who were involved in the design process. How-
ever, many of our findings on factors associated with usability 
and usage for patient-users who had been involved in the de-
sign process were also applicable to the users who had not 
been involved in the design process. 
The FTA is now the subject of an ongoing RCT [16] in which 
effects of using the FTA on diabetes management will be ex-
amined by measures of clinical outcomes and standardized 
questionnaires. We did not investigate how the regular meet-
ings with learning opportunities in Trial II might have influ-
enced FTA usage. Such meetings will not be included in the 
RCT [16], to exclude the effects that they might have on self-
management activities and diabetes control. Though the par-
ticipants in Trial I are no longer involved in design processes,
the FTA is evolving through many research projects in which
new functions are implemented and feedback for improvement 
is given [17]. Such series of studies will provide useful in-
sights into factors associated with usage and usability of a 
mobile self-management system.
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